Candel Therapeutics (CADL)

• Market cap: $356M
• 1 day: 11.72%
• 5 days: 24.38%
• 1 month: 29.08%
• 3 months: 31.71%
• 6 months: 18.68%
• Year to date: -27.92%
• 1 year: -16.39%
• 5 years: -7.43%
• 10 years: -7.43%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38